中华妇产科杂志
中華婦產科雜誌
중화부산과잡지
CHINESE JOUNAL OF OBSTETRICS AND GYNECOLOGY
2013年
3期
161-164
,共4页
黎青%李少英%张慧敏%何文智%马晓燕%王晓蔓%冼嘉嘉%孙筱放%陈敦金
黎青%李少英%張慧敏%何文智%馬曉燕%王曉蔓%冼嘉嘉%孫篠放%陳敦金
려청%리소영%장혜민%하문지%마효연%왕효만%승가가%손소방%진돈금
肌营养不良,杜氏%产前诊断%核酸扩增技术%基因缺失%外显子%突变%可重复性,结果
肌營養不良,杜氏%產前診斷%覈痠擴增技術%基因缺失%外顯子%突變%可重複性,結果
기영양불량,두씨%산전진단%핵산확증기술%기인결실%외현자%돌변%가중복성,결과
Muscular dystrophy,Duchenne%Prenatal diagnosis%Nucleic acid amplification techniques%Gene deletion%Exons%Mutation%Reproducibility of results
目的 探讨多重连接探针扩增(MLPA)技术用于假性肥大型肌营养不良症(DMD)先证者家系中高风险孕妇产前DMD基因诊断的价值.方法 收集2005年至2012年广州医学院第三附属医院、南方医科大学南方医院等4家医院的155例有DMD先证者家系的高风险孕妇,其中7例孕早期孕妇取绒毛标本,148例孕中期孕妇取羊水样本,对绒毛标本和血性羊水标本排除母体DNA污染后,采用MLPA技术对绒毛和羊水样本行胎儿DMD基因检测;计算155个家系中DMD基因外显子突变发生次数.结果 (1)155例孕妇中共检出DMD胎儿27例、胎儿DMD基因携带者28例、正常胎儿100例.155例胎儿中,男胎72例,其中27例为DMD胎儿(38%);女胎83例,其中28例胎儿为DMD基因携带者(34%).(2)27例DMD胎儿中,DMD外显子缺失突变22例(14.2%,22/155);外显子重复突变5例,(3.2%,5/155);28例DMD基因携带者中,DMD外显子杂合缺失突变25例(16.1%,25/155),外显子杂合重复突变3例(1.9%,3/155).155个家系中,DMD基因突变的发生主要分布在外显子45 ~ 52之间,其中外显子49突变发生次数最高,共22次.(3)7例早孕期孕妇的绒毛组织DMD基因诊断结果中,有两例胎儿DMD基因型分别与先证者、孕妇的DMD基因型一致,其中1例为患儿、1例为DMD基因携带者,分别给予终止妊娠和继续妊娠的处理.结论 MLPA技术用于DMD产前基因诊断,能准确区分DMD基因突变是属于缺失型、重复型突变还是杂合性缺失等,对DMD先证者家系的高危孕妇有较高的产前诊断价值,临床结果可靠;绒毛膜活检可用于产前DMD早期基因诊断.
目的 探討多重連接探針擴增(MLPA)技術用于假性肥大型肌營養不良癥(DMD)先證者傢繫中高風險孕婦產前DMD基因診斷的價值.方法 收集2005年至2012年廣州醫學院第三附屬醫院、南方醫科大學南方醫院等4傢醫院的155例有DMD先證者傢繫的高風險孕婦,其中7例孕早期孕婦取絨毛標本,148例孕中期孕婦取羊水樣本,對絨毛標本和血性羊水標本排除母體DNA汙染後,採用MLPA技術對絨毛和羊水樣本行胎兒DMD基因檢測;計算155箇傢繫中DMD基因外顯子突變髮生次數.結果 (1)155例孕婦中共檢齣DMD胎兒27例、胎兒DMD基因攜帶者28例、正常胎兒100例.155例胎兒中,男胎72例,其中27例為DMD胎兒(38%);女胎83例,其中28例胎兒為DMD基因攜帶者(34%).(2)27例DMD胎兒中,DMD外顯子缺失突變22例(14.2%,22/155);外顯子重複突變5例,(3.2%,5/155);28例DMD基因攜帶者中,DMD外顯子雜閤缺失突變25例(16.1%,25/155),外顯子雜閤重複突變3例(1.9%,3/155).155箇傢繫中,DMD基因突變的髮生主要分佈在外顯子45 ~ 52之間,其中外顯子49突變髮生次數最高,共22次.(3)7例早孕期孕婦的絨毛組織DMD基因診斷結果中,有兩例胎兒DMD基因型分彆與先證者、孕婦的DMD基因型一緻,其中1例為患兒、1例為DMD基因攜帶者,分彆給予終止妊娠和繼續妊娠的處理.結論 MLPA技術用于DMD產前基因診斷,能準確區分DMD基因突變是屬于缺失型、重複型突變還是雜閤性缺失等,對DMD先證者傢繫的高危孕婦有較高的產前診斷價值,臨床結果可靠;絨毛膜活檢可用于產前DMD早期基因診斷.
목적 탐토다중련접탐침확증(MLPA)기술용우가성비대형기영양불량증(DMD)선증자가계중고풍험잉부산전DMD기인진단적개치.방법 수집2005년지2012년엄주의학원제삼부속의원、남방의과대학남방의원등4가의원적155례유DMD선증자가계적고풍험잉부,기중7례잉조기잉부취융모표본,148례잉중기잉부취양수양본,대융모표본화혈성양수표본배제모체DNA오염후,채용MLPA기술대융모화양수양본행태인DMD기인검측;계산155개가계중DMD기인외현자돌변발생차수.결과 (1)155례잉부중공검출DMD태인27례、태인DMD기인휴대자28례、정상태인100례.155례태인중,남태72례,기중27례위DMD태인(38%);녀태83례,기중28례태인위DMD기인휴대자(34%).(2)27례DMD태인중,DMD외현자결실돌변22례(14.2%,22/155);외현자중복돌변5례,(3.2%,5/155);28례DMD기인휴대자중,DMD외현자잡합결실돌변25례(16.1%,25/155),외현자잡합중복돌변3례(1.9%,3/155).155개가계중,DMD기인돌변적발생주요분포재외현자45 ~ 52지간,기중외현자49돌변발생차수최고,공22차.(3)7례조잉기잉부적융모조직DMD기인진단결과중,유량례태인DMD기인형분별여선증자、잉부적DMD기인형일치,기중1례위환인、1례위DMD기인휴대자,분별급여종지임신화계속임신적처리.결론 MLPA기술용우DMD산전기인진단,능준학구분DMD기인돌변시속우결실형、중복형돌변환시잡합성결실등,대DMD선증자가계적고위잉부유교고적산전진단개치,림상결과가고;융모막활검가용우산전DMD조기기인진단.
Objective To investigate the clinical value of multiplex ligation-dependent probe amplification (MLPA) in the prenatal gene diagnosis of high risk pregnant women from Duchenne muscular dystrophy (DMD) families.Methods The 155 high risk pregnant women from DMD families were recruited from 2005 to 2012 in 4 hospitals in Guangzhou,such as Southern Hospital of Southern Medical University and the Third Affiliated Hospital of Guangzhou Medical University.Among all the samples,7 were chorionic villus samples taken from early-stage pregnancy and 148 were amniotic fluid samples from mid-stage pregnancy.After the maternal contamination was eliminated,the fetal DMD gene screening was carried out by using MLPA.The mutation rates in DMD exons were calculated in all the 155 families.Results (1) Among the 155 fetuses of the DMD high risk pregnant women,there were 72 male fetuses and 83 female fetuses.In the male fetuses,there were 27 sufferers(38%).In the female fetuses,there were 28 carriers(34%).And there were 100 normal fetuses.(2) Among the 27 DMD sufferers,22 cases were DMD exon homozygous deletions (14.2%,22/155) and 5 cases were DMD exon duplications (3.2%,5/155).Among the 28 carriers,25 cases were gene heterozygous deletions (16.1%,25/155) and 3 cases were gene heterozygous duplications (1.9%,3/155).In the 155 families,the DMD mutations mainly occurred in exons 45-52,and the exon 49 had the highest mutation rates of 22 times.(3) Among the 7 cases of prenatal gene diagnosis using chorionic villus samples,2 fetuses had the identical DMD genotypes with their mothers and probands.One was a DMD sufferer and the other was a carrier.Termination or continuation of pregnancy was suggested based on the genotype of the fetus.Conclusions MLPA provides an accurate method in the prenatal diagnosis of DMD.It could be used to distinguish DMD gene homozygous deletions from heterozygous deletions and duplications.Therefore,it is valuable for DMD prenatal diagnosis in high-risk women.Chorionic villus sampling can be applied to the early prenatal diagnosis for DMD disease.